Global Immunodiagnostic Device and Reagent Market Growth (Status and Outlook) 2023-2029

Global Immunodiagnostic Device and Reagent Market Growth (Status and Outlook) 2023-2029

The global Immunodiagnostic Device and Reagent market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Immunodiagnostic Device and Reagent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Immunodiagnostic Device and Reagent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Immunodiagnostic Device and Reagent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Immunodiagnostic Device and Reagent players cover Roche, Abbott, Siemens, Danaher Corporation, BD, PerkinElmer (IDS), Diametra, Sysmex Corporation and BioMerieux, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Immunodiagnosis uses antigen-antibody binding reactions to detect substances in the human body to determine diseases. Immunodiagnostic products are mostly closed products, requiring unique matching between instruments and reagents.

LPI (LP Information)' newest research report, the “Immunodiagnostic Device and Reagent Industry Forecast” looks at past sales and reviews total world Immunodiagnostic Device and Reagent sales in 2022, providing a comprehensive analysis by region and market sector of projected Immunodiagnostic Device and Reagent sales for 2023 through 2029. With Immunodiagnostic Device and Reagent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunodiagnostic Device and Reagent industry.

This Insight Report provides a comprehensive analysis of the global Immunodiagnostic Device and Reagent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immunodiagnostic Device and Reagent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immunodiagnostic Device and Reagent market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunodiagnostic Device and Reagent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunodiagnostic Device and Reagent.

This report presents a comprehensive overview, market shares, and growth opportunities of Immunodiagnostic Device and Reagent market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Device
Reagent

Segmentation by application
Hospital
Laboratory
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Abbott
Siemens
Danaher Corporation
BD
PerkinElmer (IDS)
Diametra
Sysmex Corporation
BioMerieux
DiaSorin
Bio-Rad
Thermo Fisher Scientific
Arkray
Merck
Mindray
Antu Bio
Snibe Diagnostic

Please note: The report will take approximately 2 business days to prepare and deliver.